Citrate anticoagulation for continuous venovenous hemofiltration. - Wikidata - wikimedia - TriplyDB

Citrate anticoagulation for continuous venovenous hemofiltration.

Citrate anticoagulation for continuous venovenous hemofiltration.

http://www.wikidata.org/entity/Q33382598

about

Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments Clinical review: use of renal replacement therapies in special groups of ICU patients Renal replacement therapy in acute kidney injury: controversy and consensus Promoting Kidney Function Recovery in Patients with AKI Requiring RRT.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Advances in continuous renal replacement therapy: citrate anticoagulation update.Platelet Consumption and Filter Clotting Using Two Different Membrane Sizes during Continuous Venovenous Haemodiafiltration in the Intensive Care Unit.The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients.Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs Hemostasis during low molecular weight heparin anticoagulation for continuous venovenous hemofiltration: a randomized cross-over trial comparing two hemofiltration rates.Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2).Factors affecting outcome in acute hypertriglyceridemic pancreatitis treated with plasma exchange: an observational cohort study.Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.Ability of nafamostat mesilate to prolong filter patency during continuous renal replacement therapy in patients at high risk of bleeding: a randomized controlled study.Anticoagulation, delivered dose and outcomes in CRRT: The program to improve care in acute renal disease (PICARD).Year in review in Intensive Care Medicine 2010: I. Acute renal failure, outcome, risk assessment and ICU performance, sepsis, neuro intensive care and experimentals Regional citrate anticoagulation for RRTs in critically ill patients with AKI.Clinical experience with nadroparin in patients undergoing dialysis for renal impairment.Continuous venovenous haemofiltration with citrate-buffered replacement solution is safe and efficacious in patients with a bleeding tendency: a prospective observational study.Citrate Pharmacokinetics in Critically Ill Patients with Acute Kidney Injury Citrate for continuous renal replacement therapy: safer, better and cheaper.Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.Pro/con debate: continuous versus intermittent dialysis for acute kidney injury: a never-ending story yet approaching the finish?Clinical review: anticoagulation for continuous renal replacement therapy--heparin or citrate?Simplified Citrate Anticoagulation for CRRT Without Calcium Replacement Putative novel mediators of acute kidney injury in critically ill patients: handling by continuous venovenous hemofiltration and effect of anticoagulation modalities Implementation of continuous renal replacement therapy with regional citrate anticoagulation on a surgical and trauma intensive care unit: impact on clinical and economic aspects-an observational study.Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials.The Effects of High Level Magnesium Dialysis/Substitution Fluid on Magnesium Homeostasis under Regional Citrate Anticoagulation in Critically Ill.Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.Chloride content of solutions used for regional citrate anticoagulation might be responsible for blunting correction of metabolic acidosis during continuous veno-venous hemofiltration.Citrate shows protective effects on cardiovascular and renal function in ischemia-induced acute kidney injury.Total-to-ionized calcium ratio predicts mortality in continuous renal replacement therapy with citrate anticoagulation in critically ill patients.Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice.Good-bye CRRT, here comes SLED? ... not so fast!Regional citrate anticoagulation in patients with liver failure--time for a rethink?Coordination dynamics and coordination mechanism of a new type of anticoagulant diethyl citrate with ca(2+) ions.

P2860

Q21195747-54BFF654-BB1A-4133-8523-3684AAAD7263 Q26853350-07A5A20C-E149-479D-A1B2-AD67E7B88322 Q26998864-05B677B4-5311-4844-9CB5-BB6F519CF8C8 Q30279072-D1AE5AD8-5432-4D4A-AD7F-D4DA9E1703E0 Q33399580-D54F6537-8907-407E-AEEE-159798B8B226 Q33403996-BC04E6D5-F5D4-4948-8167-00E91D5008E8 Q33415569-5669BF37-FB11-484F-8631-90BF84212020 Q33423870-2552FB7A-7D02-4A81-BDC3-F07FD8392CE9 Q33426850-572E3723-9DE7-424D-A2FE-33E44C646239 Q33587210-F5233BB2-C0B2-4D82-B911-B551A6046D35 Q33612746-40CBA192-9932-43B5-A2B4-E412D91F07CD Q33752736-319A3B52-F7DD-4B8C-8D3C-4D2B10D10817 Q33927822-B49CAA8B-37A7-443D-B272-A9536D867DC3 Q34169048-96551159-673C-4C31-9D21-4FDF64E6DED0 Q34323157-FF627207-F40A-4A38-BECA-5A0A0D5E5DA6 Q34451757-C08C3954-CE3C-4126-A621-8B2D8826190C Q34534501-196D93F2-8A4D-4B22-86A9-A25F589BE798 Q34629661-6F66FA41-818D-4F4F-8DC1-39AB1EF647E1 Q34630740-7A65068A-75E3-4EAD-888A-89583669F056 Q34676665-884826B0-174C-41FD-9C59-486B3066884E Q34792965-9DF6D1EF-F268-4D45-84A6-D8C5EEA60822 Q35091035-1DB9571E-81CB-4BE5-8FA3-A7C9C7039BBB Q35190273-6D9EE18A-B239-4620-AC08-E216D245FCA0 Q35567092-E8829F40-F2A9-4C35-B1FE-1B193A324CDF Q35567100-94F9B2DE-9AF5-43D9-817C-A5CDBDB49A4B Q35806341-26950C6D-B671-4873-B474-0EC2C1BD1170 Q35827976-18E0EBBA-6A90-4440-AD96-43160DB55D36 Q35902914-0101F621-06C4-453E-9109-9259B00C4316 Q36017130-AFDD30D8-75AD-44B4-BCA0-F947F2363F48 Q36071591-30C0E8A3-562A-4D5E-BC4C-7FB37AC44B93 Q36104484-CC2CA5B3-74D6-4974-B707-D61F898926DF Q36113753-5720243B-7F42-4DE4-8043-6674E48C5D6A Q36342440-055FA383-2822-436C-9923-EAE70EE3962A Q36633658-39FB5403-EBB6-49F5-83C0-6C44AA4C601E Q36633751-324EC6FC-2733-43F2-B5B3-7263200F8AB7 Q36634057-7F6DF9F7-3F14-49A6-BA35-F23B1877262A Q36902584-6377BED0-BE6E-4084-ADF7-A0BA696B5223 Q36902623-2BA64DA1-81A9-4D31-9F90-9E5C71F75934 Q36928083-C05AE85A-7AE5-4D7A-8BF7-89D5A891CFC9 Q37448820-05FD7163-FB20-4302-9F69-2918881FD9C9

P2860

Citrate anticoagulation for continuous venovenous hemofiltration.

http://www.wikidata.org/entity/Q33382598

description

2009 nî lūn-bûn

@nan

2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Citrate anticoagulation for continuous venovenous hemofiltration.

@ast

Citrate anticoagulation for continuous venovenous hemofiltration.

@en

type

label

Citrate anticoagulation for continuous venovenous hemofiltration.

@ast

Citrate anticoagulation for continuous venovenous hemofiltration.

@en

prefLabel

Citrate anticoagulation for continuous venovenous hemofiltration.

@ast

Citrate anticoagulation for continuous venovenous hemofiltration.

@en

P1433

Q33382598-50C31D4D-0ADD-4228-838C-B697948E7D62

P1476

Q33382598-480C8E8E-22FC-4E65-B770-FBAC390777A3

P2093

Q33382598-011F9002-223B-4B4E-A9B2-6D0F05242F32

Q33382598-0D71A306-A421-4E7F-BC0B-2AA5B3E8E689

Q33382598-4A1E7604-DB6B-4081-8142-36DB508A8BBC

Q33382598-72859750-9EA8-46C2-99B6-8B56C497D473

Q33382598-C33CADFE-AF00-4E9B-B7B4-874B53248C6C

Q33382598-C9C452E2-8F24-48AB-800F-9A7A6EDD3863

Q33382598-E7B7A709-EDDE-4019-9B54-A9786E678011

P304

Q33382598-F0706240-D8BF-4BF6-852B-BCB0B3B852EA

P31

Q33382598-5985E0C0-EAFA-41D5-A1F5-821627B8C143

P356

Q33382598-A27125C9-82D9-4356-B313-D8563B50B626

P407

Q33382598-3389FE86-B953-4993-B466-05416EE82E87

P433

Q33382598-9B017D2C-B44D-4F74-A88E-6BF68C01C94B

P478

Q33382598-A5DB6C3B-B12F-4780-9A5F-8F53BAEB1C25

P50

Q33382598-C9076A55-E529-4FD2-9D16-2E10E21ABAD2

P577

Q33382598-6FD88434-7B42-412F-A1D1-32D0866C3B73

P698

Q33382598-A208CC29-1119-4D17-9270-BC0A4F5A405D

P921

Q33382598-0CFDE659-1D76-4293-8A9A-F0AB34D9235D

P356

CCM.0B013E3181953C5E

P1433

Critical Care Medicine

P1476

Citrate anticoagulation for continuous venovenous hemofiltration.

@en

P2093

Durk F Zandstra

http://www.w3.org/2001/XMLSchema#string

Heleen M Oudemans-van Straaten

http://www.w3.org/2001/XMLSchema#string

Johan I van der Spoel

http://www.w3.org/2001/XMLSchema#string

Jos P J Wester

http://www.w3.org/2001/XMLSchema#string

Matty Koopmans

http://www.w3.org/2001/XMLSchema#string

Peter H J van der Voort

http://www.w3.org/2001/XMLSchema#string

Rob J Bosman

http://www.w3.org/2001/XMLSchema#string

P304

545-552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/CCM.0B013E3181953C5E

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19114912

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation